- Home
- AMZE vs LGVN Comparison
AMZE vs LGVN Comparison
Compare AMZE & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMZE | LGVN |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | United States | United States |
| Employees | 4 | N/A |
| Industry | Beverages (Production/Distribution) | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3M | 11.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AMZE | LGVN |
|---|---|---|
| Price | $0.28 | $0.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.00 | ★ $6.50 |
| AVG Volume (30 Days) | 762.8K | ★ 8.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $709,000.00 |
| Revenue This Year | $6,741.66 | N/A |
| Revenue Next Year | $100.61 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $0.48 |
| 52 Week High | $11.76 | $1.92 |
Technical Indicators
Market Signals| Indicator | AMZE | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 35.29 | 67.60 |
| Support Level | $0.24 | $0.55 |
| Resistance Level | $0.41 | $1.44 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 12.67 | 65.60 |
Price Performance
Historical ComparisonAbout AMZE Amaze Holdings Inc.
Amaze Holdings Inc is a software company dedicated to empowering creators by providing comprehensive software solutions and services that facilitate e-commerce, social commerce, integrated commerce selling experiences, and the distribution of a premium wine brand. The group offers an end-to-end, creator-powered commerce platform offering tools for seamless product creation, modern e-commerce solutions, and scalable managed services.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.